Dean Investment Associates LLC Sells 4,605 Shares of Encompass Health Co. (NYSE:EHC)

Dean Investment Associates LLC lessened its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,602 shares of the company's stock after selling 4,605 shares during the period. Dean Investment Associates LLC owned approximately 0.05% of Encompass Health worth $4,950,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of EHC. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares during the last quarter. Tompkins Financial Corp purchased a new stake in Encompass Health during the 4th quarter valued at $46,000. V Square Quantitative Management LLC increased its position in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after acquiring an additional 177 shares during the period. Finally, Signaturefd LLC boosted its holdings in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have weighed in on the company. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com lowered Encompass Health from a "buy" rating to a "hold" rating in a research report on Wednesday, April 16th. Royal Bank of Canada restated an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. Barclays upped their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, February 7th. Finally, KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $107.67.

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.10% of the company's stock.

Encompass Health Stock Performance

EHC traded down $7.16 during trading on Monday, hitting $96.19. The company's stock had a trading volume of 1,703,968 shares, compared to its average volume of 670,638. Encompass Health Co. has a one year low of $79.26 and a one year high of $104.84. The business's 50 day simple moving average is $99.91 and its 200-day simple moving average is $98.29. The firm has a market cap of $9.69 billion, a PE ratio of 21.57, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, sell-side analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were paid a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.71%. Encompass Health's payout ratio is presently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.